BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16809328)

  • 1. Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts.
    Frater AJ; Edwards CT; McCarthy N; Fox J; Brown H; Milicic A; Mackie N; Pillay T; Drijfhout JW; Dustan S; Clarke JR; Holmes EC; Zhang HT; Pfafferott K; Goulder PJ; McClure MO; Weber J; Phillips RE; Fidler S
    J Virol; 2006 Jul; 80(14):7226-34. PubMed ID: 16809328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.
    Leslie A; Kavanagh D; Honeyborne I; Pfafferott K; Edwards C; Pillay T; Hilton L; Thobakgale C; Ramduth D; Draenert R; Le Gall S; Luzzi G; Edwards A; Brander C; Sewell AK; Moore S; Mullins J; Moore C; Mallal S; Bhardwaj N; Yusim K; Phillips R; Klenerman P; Korber B; Kiepiela P; Walker B; Goulder P
    J Exp Med; 2005 Mar; 201(6):891-902. PubMed ID: 15781581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare HLA drive additional HIV evolution compared to more frequent alleles.
    Rousseau CM; Lockhart DW; Listgarten J; Maley SN; Kadie C; Learn GH; Nickle DC; Heckerman DE; Deng W; Brander C; Ndung'u T; Coovadia H; Goulder PJ; Korber BT; Walker BD; Mullins JI
    AIDS Res Hum Retroviruses; 2009 Mar; 25(3):297-303. PubMed ID: 19327049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants.
    Dickover R; Garratty E; Yusim K; Miller C; Korber B; Bryson Y
    J Virol; 2006 Jul; 80(13):6525-33. PubMed ID: 16775339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    Allen TM; Altfeld M; Geer SC; Kalife ET; Moore C; O'sullivan KM; Desouza I; Feeney ME; Eldridge RL; Maier EL; Kaufmann DE; Lahaie MP; Reyor L; Tanzi G; Johnston MN; Brander C; Draenert R; Rockstroh JK; Jessen H; Rosenberg ES; Mallal SA; Walker BD
    J Virol; 2005 Nov; 79(21):13239-49. PubMed ID: 16227247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.
    Kaslow RA; Rivers C; Tang J; Bender TJ; Goepfert PA; El Habib R; Weinhold K; Mulligan MJ;
    J Virol; 2001 Sep; 75(18):8681-9. PubMed ID: 11507213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.
    Gounder K; Padayachi N; Mann JK; Radebe M; Mokgoro M; van der Stok M; Mkhize L; Mncube Z; Jaggernath M; Reddy T; Walker BD; Ndung'u T
    PLoS One; 2015; 10(3):e0119886. PubMed ID: 25781986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.
    Avila-Rios S; Carlson JM; John M; Mallal S; Brumme ZL
    Curr Opin HIV AIDS; 2019 May; 14(3):194-204. PubMed ID: 30925534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.
    Kinloch NN; MacMillan DR; Le AQ; Cotton LA; Bangsberg DR; Buchbinder S; Carrington M; Fuchs J; Harrigan PR; Koblin B; Kushel M; Markowitz M; Mayer K; Milloy MJ; Schechter MT; Wagner T; Walker BD; Carlson JM; Poon AF; Brumme ZL
    J Virol; 2016 Feb; 90(3):1244-58. PubMed ID: 26559841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evolution of human immunodeficiency virus type 1 upon transmission between human leukocyte antigen disparate donor-recipient pairs.
    Navis M; Matas DE; Rachinger A; Koning FA; van Swieten P; Kootstra NA; Schuitemaker H
    PLoS One; 2008 Jun; 3(6):e2422. PubMed ID: 18560583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection.
    Gao X; O'Brien TR; Welzel TM; Marti D; Qi Y; Goedert JJ; Phair J; Pfeiffer R; Carrington M
    AIDS; 2010 Jul; 24(12):1835-40. PubMed ID: 20588164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
    Bhattacharya T; Daniels M; Heckerman D; Foley B; Frahm N; Kadie C; Carlson J; Yusim K; McMahon B; Gaschen B; Mallal S; Mullins JI; Nickle DC; Herbeck J; Rousseau C; Learn GH; Miura T; Brander C; Walker B; Korber B
    Science; 2007 Mar; 315(5818):1583-6. PubMed ID: 17363674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pre-adapted HIV transmission.
    Carlson JM; Du VY; Pfeifer N; Bansal A; Tan VY; Power K; Brumme CJ; Kreimer A; DeZiel CE; Fusi N; Schaefer M; Brockman MA; Gilmour J; Price MA; Kilembe W; Haubrich R; John M; Mallal S; Shapiro R; Frater J; Harrigan PR; Ndung'u T; Allen S; Heckerman D; Sidney J; Allen TM; Goulder PJ; Brumme ZL; Hunter E; Goepfert PA
    Nat Med; 2016 Jun; 22(6):606-13. PubMed ID: 27183217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.
    Burns DP; Desrosiers RC
    Curr Top Microbiol Immunol; 1994; 188():185-219. PubMed ID: 7523031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants.
    Milicic A; Edwards CT; Hué S; Fox J; Brown H; Pillay T; Drijfhout JW; Weber JN; Holmes EC; Fidler SJ; Zhang HT; Phillips RE
    J Virol; 2005 Nov; 79(22):13953-62. PubMed ID: 16254331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity considerations in HIV-1 vaccine selection.
    Gaschen B; Taylor J; Yusim K; Foley B; Gao F; Lang D; Novitsky V; Haynes B; Hahn BH; Bhattacharya T; Korber B
    Science; 2002 Jun; 296(5577):2354-60. PubMed ID: 12089434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.